DOCSLIB.ORG

Ndfip1 Mediates Peripheral Tolerance to Self and Exogenous Antigen by Inducing Cell Cycle Exit in Responding CD4 T Cells

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Ndfip1 Mediates Peripheral Tolerance to Self and Exogenous Antigen by Inducing Cell Cycle Exit in Responding CD4 T Cells Ndfip1 mediates peripheral tolerance to self and INAUGURAL ARTICLE exogenous antigen by inducing cell cycle exit in + responding CD4 T cells John A. Altina, Stephen R. Daleya, Jason Howittb, Helen J. Rickardsa, Alison K. Batkina, Keisuke Horikawaa, Simon J. Prasada, Keats A. Nelmsa, Sharad Kumarc, Lawren C. Wud, Seong-Seng Tanb, Matthew C. Cooka,1, and Christopher C. Goodnowa,1,2 aJohn Curtin School of Medical Research, Australian National University, Canberra, ACT 2601, Australia; bFlorey Neurosciences Institute, University of Melbourne, Parkville, VIC 3010, Australia; cCentre for Cancer Biology, University of South Australia, Adelaide, South Australia 5000, Australia; and dDepartment of Immunology, Genentech, South San Francisco, CA 94080 This contribution is part of the special series of Inaugural Articles by members of the National Academy of Sciences elected in 2013. Contributed by Christopher C. Goodnow, December 17, 2013 (sent for review October 13, 2013) The NDFIP1 (neural precursor cell expressed, developmentally down- (11), rheumatoid arthritis (12), and multiple sclerosis (13). It regulated protein 4 family-interacting protein 1) adapter for the remains unclear which cellular mechanisms of tolerance are ubiquitin ligase ITCH is genetically linked to human allergic and auto- disrupted by these genetic variants to result in allergic and immune disease, but the cellular mechanism by which these proteins autoimmune disease. enable foreign and self-antigens to be tolerated is unresolved. Here, Ndfip1 and Itch were first revealed as important immune we use two unique mouse strains—an Ndfip1-YFP reporter and an regulators in mouse genetic studies. Homozygous inactivating Ndfip1-deficient strain—to show that Ndfip1 is progressively in- mutations in the Itchy strain cause dermatitis, lung mononuclear duced during T-cell differentiation and activation in vivo and that inflammation, lymphadenopathy with follicular hyperplasia, in- – its deficiency causes a cell-autonomous, Forkhead box P3-indepen- creased activated T cells (notably IL-4 producing Th2 cells), + dent failure of peripheral CD4 T-cell tolerance to self and exogenous expansion of B1b cells in the peritoneal cavity, and early death IMMUNOLOGY + antigen. In small cohorts of antigen-specific CD4 cells responding (5, 6, 14, 15). Although the murine pathology has often been in vivo, Ndfip1 was necessary for tolerogen-reactive T cells to exit described as autoimmune because of its spontaneous de- cell cycle after one to five divisions and to abort Th2 effector differ- velopment, there is currently little direct evidence of T-cell au- toimmunity, and the predominant inflammation of skin and entiation, defining a step in peripheral tolerance that provides mucosal surfaces suggests an exaggerated response to innocuous insights into the phenomenon of T-cell anergy in vivo and is distinct environmental antigens. Indeed, elegant studies showed that Itch from the better understood process of Bcl2-interacting mediator Ndfip1 deficiency prevents high-zone tolerance in an experimental of cell death-mediated apoptosis. deficiency precipitated model of respiratory exposure to an egg protein allergen (16). autoimmune pancreatic destruction and diabetes; however, this An almost identical skin and lung inflammatory syndrome occurs depended on a further accumulation of nontolerant anti-self T cells in mice inheriting a homozygous gene-trap insertion that greatly from strong stimulation by exogenous tolerogen. These findings reduces Ndfip1 mRNA and protein (2). Although much progress illuminate a peripheral tolerance checkpoint that aborts T-cell has been made elucidating diverse biochemical functions of Itch clonal expansion against allergens and autoantigens and demon- strate how hypersensitive responses to environmental antigens may Significance trigger autoimmunity. Advances in organ transplantation and treatment of allergy immunological tolerance | allergy | T lymphocyte | Interleukin-4 | and autoimmune disease hinge upon harnessing a physiologi- Aire (Autoimmune Regulator) cal switch that allows T cells to decide between proliferating extensively or actively becoming tolerant. The experiments n healthy individuals, mature T cells in peripheral lymphoid presented here illuminate a critical element of this natural switch, Itissues proliferate and acquire effector functions in response to Ndfip1 (neural precursor cell expressed, developmentally down- antigens from pathogenic microbes but remain tolerant to self- regulated protein 4 family-interacting protein 1), a partner pro- antigens and innocuous environmental antigens. Defects in this tein of ubiquitin ligases induced during the first several divisions phenomenon of “peripheral T-cell tolerance” are thought to after T cells encounter antigen. They define the cellular action of contribute to the burden of autoimmune and allergic disease, but Ndfip1 in vivo, acting within dividing helper T cells that have there is only a fragmented understanding of its cellular basis, its responded to innocuous foreign or self-antigen that should connection to specific genetic circuits, and the interconnection normally be tolerated, to force their exit from cell cycle before between autoimmunity and hypersensitivity to exogenous anti- they have divided so many times that they acquire tissue-dam- gens (1). This problem is exemplified by the genetic circuit aging effector functions. encoding Ndfip1 [neural precursor cell expressed, developmentally down-regulated protein 4 (NEDD4) family-interacting protein 1], Author contributions: J.A.A., S.R.D., J.H., H.J.R., A.K.B., K.H., S.J.P., K.A.N., L.C.W., S.-S.T., M.C.C., and C.C.G. designed research; J.A.A., S.R.D., J.H., H.J.R., A.K.B., K.H., S.J.P., K.A.N., a transmembrane protein localized to the Golgi and intracellular and M.C.C. performed research; J.H., S.K., and S.-S.T. contributed new reagents/analytic vesicles that recruits and activates the HECT-type E3 ubiquitin tools; J.A.A., S.R.D., J.H., H.J.R., A.K.B., K.H., K.A.N., L.C.W., S.-S.T., M.C.C., and C.C.G. ligase Itch (2–7). Human genetic studies have associated NDFIP1 analyzed data; and J.A.A., S.R.D., M.C.C., and C.C.G. wrote the paper. and ITCH with allergic and autoimmune diseases. Inherited ITCH The authors declare no conflict of interest. deficiency results in asthma-like chronic lung disease with non- Freely available online through the PNAS open access option. fibrotic lymphocytic pneumonitis (90% cases) and organ-specific 1M.C.C. and C.C.G. contributed equally to this work. autoimmunity (60% cases) variably involving the thyroid, liver, 2To whom correspondence should be addressed. E-mail: [email protected]. intestine, or pancreatic islets (8). Inherited NDFIP1 polymorphisms This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. are associated with inflammatory bowel disease (9, 10), asthma 1073/pnas.1322739111/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1322739111 PNAS | February 11, 2014 | vol. 111 | no. 6 | 2067–2074 Downloaded by guest on October 2, 2021 and Ndfip1 in many cell types (3, 17), the cellular basis for im- A BC mune dysregulation in their absence is unresolved, and their role C -58 nt in T-cell tolerance to self-antigens has yet to be examined. Exon 4 Exon 5 Exon 6 KO mutant Defects in several different cellular mechanisms for peripheral Wt: GTATG…….GG gt wild-type Mut: GTATG…….GG at -125 nt T-cell tolerance have been implicated in the inflammatory dis- -58 nt PY? ease caused by defects in the Itch-Ndfip1 genetic circuit. T-cell -125 nt PY2 Ndfip1 anergy is a mechanism defined initially in tissue culture that PY1 prevents initiation of T-cell proliferation when T cells are stim- D N ulated without a CD28 costimulus (18). Itch was required for 100 100 T-cell anergy in cultured cells rendered anergic by prolonged in 80 80 60 60 vitro treatment with ionomycin or harvested from TCR trans- 40 40 tubulin genic (Tg) mice 10 d after exposure to a high-tolerogenic dose of 20 20 foreign antigen. An intact Itch gene was correlated with di- 0 % surviving 0 % dermatitis-free 0 100 200 0 100 200 minished TCR signaling and proteolytic degradation of protein age (days) age (days) θ γ kru/kru +/+ , +/– kinase C (PKC)- , phospholipase C (PLC)- , JunB, and c-Jun Ndfip1(n=13)(n=13) Rag (n=13) kru/kru –/– proteins (16, 19). A role for Itch in nondegradative ubiquitina- Ndfip1(n=27)(n=27) Rag (n=27) tion of the TCR CD3 ζ subunit to inhibit its phosphorylation and the activation of Zap-70 has also been shown (20). Likewise, Fig. 1. Immune-mediated lethal inflammatory syndrome in mice with Ndfip1 deficiency causes JunB accumulation (2) and allows T a truncating Ndfip1 splice site mutation. (A) Schematic showing the location of the Ndfip1kru mutation within the Ndfip1 exon 5 splice donor sequence cells to make IL-2 for a sustained period in vitro without the and the resulting two aberrant splice products. (B) Schematic showing the need for CD28 costimulation (21). Itch-deficient T cells also κ α topology of the Ndfip1 protein and position of the truncating mutations. (C) display exaggerated NF- B signaling in response to TNF- , be- Western blot of primary T-cell lysates from wild-type, Ndfip1kru/kru (mutant), − − cause Itch forms a complex that recruits Tnfaip3 to terminate and Ndfip1 / (KO) mice, probed with an antibody raised to a conserved N- NF-κB signaling (22). Itch has also been implicated in ubiquiti- terminal peptide of Ndfip1, and then stripped and reprobed with antibody nation and degradation of Bcl-10, an adaptor protein with an to tubulin to assess loading. (D) Dermatitis and survival of Ndfip1kru/kru mice essential role in TCR and CD28 signaling to NF-κB (23). TCR- with normal or null Rag1 genes, aged to 250 d or until moribund necessi- activated T cells that lack Itch or Ndfip1 form a diminished tating the animal to be killed.
Load more

Recommended publications
  • AIRE Variations in Addison's Disease and Autoimmune Polyendocrine Syndromes
    Genes and Immunity (2008) 9, 130–136 & 2008 Nature Publishing Group All rights reserved 1466-4879/08 $30.00 www.nature.com/gene ORIGINAL ARTICLE AIRE variations in Addison’s disease and autoimmune polyendocrine syndromes (APS): partial gene deletions contribute to APS I AS Bøe Wolff1,2,3,7, B Oftedal1,2,7, S Johansson3,4, O Bruland3, K Løva˚s1,2, A Meager5, C Pedersen6, ES Husebye1,2 and PM Knappskog3,4 1Institute of Medicine, University of Bergen, Bergen, Norway; 2Department of Medicine, Haukeland University Hospital, Bergen, Norway; 3Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway; 4Department of Clinical Medicine, University of Bergen, Bergen, Norway; 5Biotherapeutics Group, The National Institute for Biological Standards and Control, Blanche Lane, South Mimms, Herts, UK and 6Department of Pediatrics, Kolding Hospital, Kolding, Denmark Autoimmune Addison’s disease (AAD) is often associated with other components in autoimmune polyendocrine syndromes (APS). Whereas APS I is caused by mutations in the AIRE gene, the susceptibility genes for AAD and APS II are unclear. In the present study, we investigated whether polymorphisms or copy number variations in the AIRE gene were associated with AAD and APS II. First, nine SNPs in the AIRE gene were analyzed in 311 patients with AAD and APS II and 521 healthy controls, identifying no associated risk. Second, in a subgroup of 25 of these patients, AIRE sequencing revealed three novel polymorphisms. Finally, the AIRE copy number was determined by duplex quantitative PCR in 14 patients with APS I, 161 patients with AAD and APS II and in 39 healthy subjects.
    [Show full text]
  • Sexual Dimorphism in the Immune Response: Endocrinologic and Genetic Insights
    RIJKSUNIVERSITEIT GRONINGEN Sexual dimorphism in the immune response: endocrinologic and genetic insights Author: Lisa Wanders Supervisor: Dr. M.M. Faas Master-essay 29.05.2016 Sexual dimorphism in the immune response: endocrinologic and genetic insights Author: Lisa Wanders Supervisor: Dr. M.M. Faas Group: Medical Biology Abstract Differences in the immune response exist between men and women. While females have a stronger adaptive immune response, including the cellular and humoral response, males have a stronger and more sensitive innate immune response. This essay reviews these differences and focuses on sex hormones and genetics as possible underlying causes. The implications for a variety of conditions are discussed. Females have a higher predisposition to acquire autoimmune diseases and are more susceptible to acute graft rejections but are at the same time more resistant to infections and gain better protection from vaccinations. Males on the other hand have a higher risk to develop multiple organ failure after trauma and severe infections after surgery. Moreover, higher rates of sepsis are observed in males compared to females. Despite extensive research in this field, many of the mechanisms underlying the sexual dimorphism in the immune response are still unknown. 1 Table of contents 1. Introduction ..................................................................................................................................... 3 2. Sex-based differences in the immune response ............................................................................
    [Show full text]
  • CBL Mutations in Myeloproliferative Neoplasms Are Also Found in the Gene’S Proline-Rich Domain and in Patients with the V617FJAK2
    Articles and Brief Reports Chronic Myeloproliferative Disorders CBL mutations in myeloproliferative neoplasms are also found in the gene’s proline-rich domain and in patients with the V617FJAK2 Paula Aranaz,1 Cristina Hurtado,1 Ignacio Erquiaga,1 Itziar Miguéliz,1 Cristina Ormazábal,1 Ion Cristobal,2 Marina García-Delgado,1 Francisco Javier Novo,1 and José Luis Vizmanos1 1Department of Genetics, School of Sciences, University of Navarra, Pamplona; and 2CIMA, Center for Applied Medical Research, University of Navarra, Pamplona, Spain ABSTRACT Funding: this work was funded Background with the help of the Spanish Despite the discovery of the p.V617F in JAK2, the molecular pathogenesis of some chronic myelo- Ministry of Science and Innovation proliferative neoplasms remains unclear. Although very rare, different studies have identified CBL (SAF 2007-62473), the PIUNA (Cas-Br-Murine ecotropic retroviral transforming sequence) mutations in V617FJAK2-negative Program of the University of patients, mainly located in the RING finger domain. In order to determine the frequency of CBL Navarra, the Caja Navarra Foundation through the Program mutations in these diseases, we studied different regions of all CBL family genes (CBL, CBLB and “You choose, you decide” (Project CBLC) in a selected group of patients with myeloproliferative neoplasms. We also included 10.830) and ISCIII-RTICC V617FJAK2-positive patients to check whether mutations in CBL and JAK2 are mutually exclusive (RD06/0020/0078). events. PA received a predoctoral grant from the Government of Navarra. Design and Methods Using denaturing high performance liquid chromatography, we screened for mutations in CBL, Manuscript received on CBLB and CBLC in a group of 172 V617FJAK2-negative and 232 V617FJAK2-positive patients July 26, 2011.
    [Show full text]
  • Supplementary Information Method CLEAR-CLIP. Mouse Keratinocytes
    Supplementary Information Method CLEAR-CLIP. Mouse keratinocytes of the designated genotype were maintained in E-low calcium medium. Inducible cells were treated with 3 ug/ml final concentration doxycycline for 24 hours before performing CLEAR-CLIP. One 15cm dish of confluent cells was used per sample. Cells were washed once with cold PBS. 10mls of cold PBS was then added and cells were irradiated with 300mJ/cm2 UVC (254nM wavelength). Cells were then scraped from the plates in cold PBS and pelleted by centrifugation at 1,000g for 2 minutes. Pellets were frozen at -80oC until needed. Cells were then lysed on ice with occasional vortexing in 1ml of lysis buffer (50mM Tris-HCl pH 7.4, 100mM NaCl, 1mM MgCl2, 0.1 mM CaCl2, 1% NP-40, 0.5% Sodium Deoxycholate, 0.1% SDS) containing 1X protease inhibitors (Roche #88665) and RNaseOUT (Invitrogen #10777019) at 4ul/ml final concentration. Next, TurboDNase (Invitrogen #AM2238, 10U), RNase A (0.13ug) and RNase T1 (0.13U) were added and samples were incubated at 37oC for 5 minutes with occasional mixing. Samples were immediately placed on ice and then centrifuged at 16,160g at 4oC for 20 minutes to clear lysate. 25ul of Protein-G Dynabeads (Invitrogen #10004D) were used per IP. Dynabeads were pre-washed with lysis buffer and pre- incubated with 3ul of Wako Anti-Mouse-Ago2 (2D4) antibody. The dynabead/antibody mixture was added to the lysate and rocked for 2 hours at 4oC. All steps after the IP were done on bead until samples were loaded into the polyacrylamide gel.
    [Show full text]
  • Ncounter® Mouse Autoimmune Profiling Panel - Gene and Probe Details
    nCounter® Mouse AutoImmune Profiling Panel - Gene and Probe Details Official Symbol Accession Alias / Previous Symbol Official Full Name Other targets or Isoform Information AW208573,CD143,expressed sequence AW208573,MGD-MRK- Ace NM_009598.1 1032,MGI:2144508 angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 2610036I19Rik,2610510L13Rik,Acinus,apoptotic chromatin condensation inducer in the nucleus,C79325,expressed sequence C79325,MGI:1913562,MGI:1919776,MGI:2145862,mKIAA0670,RIKEN cDNA Acin1 NM_001085472.2 2610036I19 gene,RIKEN cDNA 2610510L13 gene apoptotic chromatin condensation inducer 1 Acp5 NM_001102405.1 MGD-MRK-1052,TRACP,TRAP acid phosphatase 5, tartrate resistant 2310066K23Rik,AA960180,AI851923,Arp1b,expressed sequence AA960180,expressed sequence AI851923,MGI:2138136,MGI:2138359,RIKEN Actr1b NM_146107.2 cDNA 2310066K23 gene ARP1 actin-related protein 1B, centractin beta Adam17 NM_001277266.1 CD156b,Tace,tumor necrosis factor-alpha converting enzyme a disintegrin and metallopeptidase domain 17 ADAR1,Adar1p110,Adar1p150,AV242451,expressed sequence Adar NM_001038587.3 AV242451,MGI:2139942,mZaADAR adenosine deaminase, RNA-specific Adora2a NM_009630.2 A2AAR,A2aR,A2a, Rs,AA2AR,MGD-MRK-16163 adenosine A2a receptor Ager NM_007425.2 RAGE advanced glycosylation end product-specific receptor AI265500,angiotensin precursor,Aogen,expressed sequence AI265500,MGD- Agt NM_007428.3 MRK-1192,MGI:2142488,Serpina8 angiotensinogen (serpin peptidase inhibitor, clade A, member 8) Ah,Ahh,Ahre,aromatic hydrocarbon responsiveness,aryl hydrocarbon
    [Show full text]
  • Anti-CBLB Antibody (ARG57312)
    Product datasheet [email protected] ARG57312 Package: 100 μl anti-CBLB antibody Store at: -20°C Summary Product Description Rabbit Polyclonal antibody recognizes CBLB Tested Reactivity Hu, Ms Tested Application IHC-P, WB Host Rabbit Clonality Polyclonal Isotype IgG Target Name CBLB Antigen Species Human Immunogen Recombinant Protein of Human CBLB. Conjugation Un-conjugated Alternate Names Nbla00127; EC 6.3.2.-; RNF56; Signal transduction protein CBL-B; Casitas B-lineage lymphoma proto- oncogene b; SH3-binding protein CBL-B; Cbl-b; E3 ubiquitin-protein ligase CBL-B; RING finger protein 56 Application Instructions Application table Application Dilution IHC-P 1:50 - 1:200 WB 1:500 - 1:2000 Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist. Positive Control Jurkat Calculated Mw 109 kDa Properties Form Liquid Purification Affinity purification with immunogen. Buffer PBS (pH 7.3), 0.02% Sodium azide and 50% Glycerol. Preservative 0.02% Sodium azide Stabilizer 50% Glycerol Storage instruction For continuous use, store undiluted antibody at 2-8°C for up to a week. For long-term storage, aliquot and store at -20°C. Storage in frost free freezers is not recommended. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use. Note For laboratory research only, not for drug, diagnostic or other use. www.arigobio.com 1/2 Bioinformation Gene Symbol CBLB Gene Full Name Cbl proto-oncogene B, E3 ubiquitin protein ligase Function E3 ubiquitin-protein ligase which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes, and transfers it to substrates, generally promoting their degradation by the proteasome.
    [Show full text]
  • Our Environment Shapes Us: the Importance of Environment and Sex Differences in Regulation of Autoantibody Production
    REVIEW published: 08 March 2018 doi: 10.3389/fimmu.2018.00478 Our Environment Shapes Us: The Importance of Environment and Sex Differences in Regulation of Autoantibody Production Michael Edwards, Rujuan Dai and S. Ansar Ahmed* Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech, Blacksburg, VA, United States Consequential differences exist between the male and female immune systems’ ability to respond to pathogens, environmental insults or self-antigens, and subsequent effects on immunoregulation. In general, females when compared with their male counterparts, respond to pathogenic stimuli and vaccines more robustly, with heightened production of antibodies, pro-inflammatory cytokines, and chemokines. While the precise reasons for sex differences in immune response to different stimuli are not yet well understood, females are more resistant to infectious diseases and much more likely to develop auto- Edited by: Ralf J. Ludwig, immune diseases. Intrinsic (i.e., sex hormones, sex chromosomes, etc.) and extrinsic University of Lübeck, (microbiome composition, external triggers, and immune modulators) factors appear to Germany impact the overall outcome of immune responses between sexes. Evidence suggests Reviewed by: Ayanabha Chakraborti, that interactions between environmental contaminants [e.g., endocrine disrupting chemi- University of Alabama at cals (EDCs)] and host leukocytes affect the ability of the immune system to mount a Birmingham, United States response to exogenous and endogenous insults, and/or return to normal activity following Jun-ichi Kira, Kyushu University, Japan clearance of the threat. Inherently, males and females have differential immune response Maja Wallberg, to external triggers. In this review, we describe how environmental chemicals, including University of Cambridge, United Kingdom EDCs, may have sex differential influence on the outcome of immune responses through *Correspondence: alterations in epigenetic status (such as modulation of microRNA expression, gene S.
    [Show full text]
  • Express Yourself Immune Evasion by Anthrax
    HIGHLIGHTS MACROPHAGES Bacillus anthracis, the causative agent (LPS)-activated macrophages. First, of anthrax, kills macrophages and they showed that LT causes the apop- evades the host immune response by tosis of LPS-treated macrophages; secreting a protein that leads to the then, they investigated the signalling Immune evasion inhibition of p38 mitogen-activated pathways involved. At the concentra- LF protein kinase (p38 MAPK), accord- tion that is required to induce apopto- by anthrax PA ing to a report in Science.The activity sis, LT inhibits the activation of ERK, of this MAPK is required for the c-Jun NH2-terminal kinase 1 (JNK1) transcription of certain downstream and p38, but the activity of JNK2 and nuclear factor-κB (NF-κB) targets. inhibitor of NF-κB (IκB) kinase (IKK) LT Macrophage Three proteins secreted by B. anthr- is unaffected. The authors used spe- acis are important for its pathogenic- cific MAPK inhibitors to determine ity: protective antigen (PA), oedema the contribution of these MAPK cas- factor (EF) and lethal factor (LF). PA cades to LT-induced apoptosis. Only enables EF and LF to enter the cytosol the p38-specific inhibitor (SB202190) of host cells, where EF causes tissue induced apoptosis of LPS-activated oedema and LF acts as a metallopro- macrophages, which indicates that LT X tease, cleaving MAPK kinases (MKKs) might cause apoptosis by inhibiting P and thereby preventing MAPK activa- p38 signalling. MKKs p38 X tion. Lethal toxin (LT; a complex of Macrophages lacking IKK and activated PA and LF) has been shown NF-κB activity were shown to be sen- to be cytotoxic for macrophages, but it sitive to LPS-induced apoptosis also.
    [Show full text]
  • Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR
    Published OnlineFirst June 26, 2018; DOI: 10.1158/0008-5472.CAN-17-3858 Cancer Tumor Biology and Immunology Research Upregulation of E3 Ubiquitin Ligase CBLC Enhances EGFR Dysregulation and Signaling in Lung Adenocarcinoma Shiao-Ya Hong1, Yu-Rung Kao1, Te-Chang Lee1, and Cheng-Wen Wu1,2,3,4 Abstract CBLC (CBL proto-oncogene c) belongs to the CBL protein ubiquitinated and positively regulated aEGFR stability family, which has E3 ubiquitin ligase activity toward activated through the conjugation of polyubiquitin by K6 and K11 receptor tyrosine kinases. CBLC is frequently upregulated in linkages. This CBLC-mediated polyubiquitination promoted non–small cell lung cancer (NSCLC), yet very little is known either preferential recycling of aEGFR back to the plasma about the functions of CBLC in tumorigenesis. Here we show membrane or trafficking to the cell nucleus. IHC analyses that CBLC is an epigenetically demethylated target and its revealed a positive correlation between phospho-EGFR and expression can be upregulated in NSCLC after treatment with CBLC in lung adenocarcinoma. In summary, we demonstrate a the DNA methylation inhibitor 50-azacytidine. Depletion novel mechanism by which aEGFR escapes lysosomal degra- of CBLC significantly inhibited cell viability and clonogenicity dation in a CBLC/ubiquitin-dependent manner to sustain its in vitro and reduced tumor growth in a xenograft model. CBLC activation. Our work identifies CBLC as a potential diagnostic silencing further sensitized EGFR-mutated NSCLC cells to biomarker and also points to its utilization as a novel thera- treatment with tyrosine kinase inhibitors. Conversely, ectopic peutic target for NSCLC therapy. expression of CBLC enhanced the activation of EGFR and downstream ERK1/2 signaling after ligand stimulation by Significance: This work demonstrates the role of CBLC expres- competing with CBL for EGFR binding.
    [Show full text]
  • Role of Genomic Variants in the Response to Biologics Targeting Common Autoimmune Disorders
    Role of genomic variants in the response to biologics targeting common autoimmune disorders by Gordana Lenert, PhD The thesis submitted to the Faculty of Graduate and Postdoctoral Affairs in partial fulfillment of the requirements for the degree of Master of Science Ottawa-Carleton Joint Program in Bioinformatics Carleton University Ottawa, Canada © 2016 Gordana Lenert Abstract Autoimmune diseases (AID) are common chronic inflammatory conditions initiated by the loss of the immunological tolerance to self-antigens. Chronic immune response and uncontrolled inflammation provoke diverse clinical manifestations, causing impairment of various tissues, organs or organ systems. To avoid disability and death, AID must be managed in clinical practice over long periods with complex and closely controlled medication regimens. The anti-tumor necrosis factor biologics (aTNFs) are targeted therapeutic drugs used for AID management. However, in spite of being very successful therapeutics, aTNFs are not able to induce remission in one third of AID phenotypes. In our research, we investigated genomic variability of AID phenotypes in order to explain unpredictable lack of response to aTNFs. Our hypothesis is that key genetic factors, responsible for the aTNFs unresponsiveness, are positioned at the crossroads between aTNF therapeutic processes that generate remission and pathogenic or disease processes that lead to AID phenotypes expression. In order to find these key genetic factors at the intersection of the curative and the disease pathways, we combined genomic variation data collected from publicly available curated AID genome wide association studies (AID GWAS) for each disease. Using collected data, we performed prioritization of genes and other genomic structures, defined the key disease pathways and networks, and related the results with the known data by the bioinformatics approaches.
    [Show full text]
  • Brief Genetics Report
    Brief Genetics Report The Rat Diabetes Susceptibility Locus Iddm4 and at Least One Additional Gene Are Required for Autoimmune Diabetes Induced by Viral Infection Elizabeth P. Blankenhorn,1 Lucy Rodemich,1 Cristina Martin-Fernandez,1 Jean Leif,2 Dale L. Greiner,2 and John P. Mordes2 BBDR rats develop autoimmune diabetes only after challenge with environmental perturbants. These per- turbants include polyinosinic:polycytidylic acid (poly ype 1 diabetes results from inflammatory infiltra- I:C, a ligand of toll-like receptor 3), agents that deplete tion of pancreatic islets and selective ␤-cell regulatory T-cell (Treg) populations, and a non–␤-cell destruction. It is thought to be caused by envi- cytopathic parvovirus (Kilham rat virus [KRV]). The Tronmental factors operating in a genetically sus- dominant diabetes susceptibility locus Iddm4 is re- ceptible host (1,2). Susceptibility loci include the major quired for diabetes induced by treatment with poly I:C histocompatibility complex (MHC), a promoter polymor- plus Treg depletion. Iddm4 is penetrant in congenic phism of the insulin gene, and an allelic variant of CTLA4 heterozygous rats on the resistant WF background and (3). Among candidate environmental perturbants, viral is 79% sensitive and 80% specific as a predictor of infection is one of the most likely (4). How genes interact induced diabetes. Surprisingly, an analysis of 190 BBDR ؋ WF)F2 rats treated with KRV after brief with the environment to transform diabetes susceptibility) exposure to poly I:C revealed that the BBDR-origin into overt disease is unknown. allele of Iddm4 is necessary but not entirely sufficient BBDR rats model virus-induced autoimmune diabetes for diabetes expression.
    [Show full text]
  • Polymorphic Variation in the CBLB Gene in Human Type 1 Diabetes
    Genes and Immunity (2004) 5, 232–235 & 2004 Nature Publishing Group All rights reserved 1466-4879/04 $25.00 www.nature.com/gene BRIEF COMMUNICATION Polymorphic variation in the CBLB gene in human type 1 diabetes R Kosoy1,2, N Yokoi3, S Seino3,4 and P Concannon1,2 1Molecular Genetics Program, Benaroya Research Institute, Seattle, WA, USA; 2Department of Immunology, University of Washington School of Medicine, Seattle, WA, USA; 3Division of Cellular and Molecular Medicine, Kobe University Graduate School of Medicine, Kobe, Japan; 4Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan CBLB was evaluated as a candidate gene for type 1 diabetes (T1D) susceptibility based on its association with autoimmunity in animal models and its role in T-cell costimulatory signaling. Cblb is one of the two major diabetes predisposing loci in the Komeda diabetes-prone (KDP) rat. Cbl-b, a ubiquitin ligase, couples TCR-mediated stimulation with the requirement for CD28 costimulation, regulating T-cell activation. To identify variants with possible effects on gene function as well as haplotype tagging polymorphisms, the human CBLB coding region was sequenced in 16 individuals with T1D: no variants predicted to change the amino-acid sequence were identified. Seven single-nucleotide polymorphism (SNP) markers spanning the CBLB gene were genotyped in multiplex T1D families and assessed for disease association by transmission disequilibrium testing. No significant evidence of association was obtained for either individual markers or marker haplotypes. Genes and Immunity (2004) 5, 232–235. doi:10.1038/sj.gene.6364057 Published online 12 February 2004 Keywords: diabetes; T cell; SNP; haplotype Introduction studies in human T1D families and studies in the NOD mouse model of T1D.9,10 Type I diabetes (T1D) arises from autoimmune destruc- In the current study, we have evaluated another tion of the insulin-secreting b-cells of the pancreas candidate T1D gene, CBLB, which is implicated based requiring insulin replacement therapy for survival.
    [Show full text]